Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Cayman Chemical BAY-3827, Purity: ≥98%, CAS: 2377576-35-5, 5 mg
SDP

Catalog No. 502944315
Encompass_Preferred

An AMPK inhibitor (IC50 = 1.4 nM at 10 µM ATP); selective for AMPK over Aurora A kinase, FLT3, and c-Met (IC50s = 1,324, 124, and 788 nM, respectively), RSK2, RSK3, RSK4, MSK1, and MST3 (IC50s = 52, 36, 24, 43, and 94 nM, respectively), and a panel of 331 kinases at 10 µM but does inhibit RSK1 (IC50 = 9 nM); selectively inhibits the proliferation of androgen-dependent LNCaP, VCaP, and 22Rv1 prostate cancer cells (IC50s = 0.28, 1.71, and 5.55 µM, respectively) over androgen receptor-negative C4-2B, PC3, and DU145 prostate cancer cells (IC50s = >10 µM for all)

Catalog No. 50-294-4315 Supplier Cayman Chemical Supplier No. 414485 MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

An AMPK inhibitor (IC50 = 1.4 nM at 10 µM ATP); selective for AMPK over Aurora A kinase, FLT3, and c-Met (IC50s = 1,324, 124, and 788 nM, respectively), RSK2, RSK3, RSK4, MSK1, and MST3 (IC50s = 52, 36, 24, 43, and 94 nM, respectively), and a panel of 331 kinases at 10 µM but does inhibit RSK1 (IC50 = 9 nM); selectively inhibits the proliferation of androgen-dependent LNCaP, VCaP, and 22Rv1 prostate cancer cells (IC50s = 0.28, 1.71, and 5.55 µM, respectively) over androgen receptor-negative C4-2B, PC3, and DU145 prostate cancer cells (IC50s = >10 µM for all)

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.